Notice I have taken keen interest into this company....just sharing my view and updates.
Recommendations:
1) CIMB - OUTPERFORM, target price - S$0.96
2) OCBC - BUY, target price - S$0.87
News update:
China's National Development andReform Commission (NRDC) announced its latest price changes to 354 drugs,effective 26 Jan 07. Over 240 drug prices were cut by an average of 20%while prices of 100+ drugs' were increased. APHM announced yesterday that 3patented drugs were affected (Maitongna, Okai and Sidinuo).
Strong fundamentals with its aquisitions and monoply on some drugs will result in only a marginal hit from the news. Strong ability to adapt to the recent regulatory changes in the China drug industry proves its ability.
Current Stock Watch: Asiapharm, Sapphire, Aztech, Lifebrandz, Hong Leong Asia
No comments:
Post a Comment